SCHEMBL27468615

SCHEMBL27468615

O=[N+]([O-])c1ccc(Cl)c(-c2nccs2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.49
CCNB2 O95067 1/20 0.44
CDK1 P06493 1/20 0.44
CCNB1 P14635 1/20 0.44
CCNA2 P20248 1/20 0.44
CDK2 P24941 1/20 0.44
CCNA1 P78396 1/20 0.44
CCNB3 Q8WWL7 1/20 0.44
VCAM1 P19320 1/20 0.42
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
PDE7A Q13946 2/20 0.41
AMY1A P0DUB6 1/20 0.41
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 2/20 0.40
PTPRC P08575 1/20 0.40
S100A4 P26447 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27694793 0.84 TDP1 (0.45) LMNAMAPTKDM4ENPC1MEN1
SCHEMBL2651269 0.82 ALDH1A1 (0.46) LMNAMAPTAMY1AKDM4ENPC1
SCHEMBL27987415 0.81 MAPT (0.45) LMNAMAPTKDM4ENPC1MEN1
SCHEMBL10966887 0.79 CYP3A4 (0.49) LMNAMAPTKDM4ENPC1MEN1
SCHEMBL28146143 0.79 LMNA (0.43) LMNAMAPTKDM4ENPC1MEN1
SCHEMBL27557457 0.79 PTGS2 (0.51) MAPTKMT2APTPRCS100A4RAB9A
SCHEMBL7263542 0.78 MEN1 (0.45) HSD17B10CCNB2CDK1CCNB1CCNA2
SCHEMBL15668204 0.76 CCNB2 (0.53) HSD17B10CCNB2CDK1CCNB1CCNA2
SCHEMBL8396786 0.76 PTPRC (0.38) LMNAMAPTKDM4ENPC1MEN1
SCHEMBL2029417 0.76 FBP1 (0.45) HSD17B10MAPTKDM4ENPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1138458-A Treatment and prevention of prostatic cancer LILLY CO ELI (US) 1996-12-25 CN disclosed